HBsAg seroclearance in chronic hepatitis B in the Chinese: Virological, histological, and clinical aspects
Man‐Fung Yuen, Danny Ka‐Ho Wong, Erwin Sablon, Eric Tse, Irene Oi‐Lin Ng, He‐Jun Yuan, Chung‐Wah Siu, Tamara J. Sander, Eric J. Bourne, Jeff G. Hall, Lynn D. Condreay, Ching‐Lung Lai – 27 May 2004 – Few studies have examined Chinese patients with chronic hepatitis B who exhibit hepatitis B surface antigen (HBsAg) seroclearance. We comprehensively studied the biochemical, virological, histological, and clinical aspects of 92 patients with HBsAg seroclearance (median follow‐up, 126 months).